Genetic instability in the 9q22.3 region is a late event in the development of squamous cell carcinoma

Oncogene

Volumn 17, Issue 14, 1998, Pages 1837-1843

  Ahmadian, Afshin ^a   Ren, Zhi Ping ^b   Williams, Cecilia ^a   Pontén, Fredrik ^b   Odeberg, Jacob ^a   Pontén, Jan ^b   Uhlén, Mathias ^a   Lundeberg, Joakim ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

9q22.3; Dysplasia; Loss of heterozygosity; p53; Squamous cell carcinoma

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER GENETICS; CARCINOMA IN SITU; CHROMOSOME 9P; CONTROLLED STUDY; DYSPLASIA; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MUTATION RATE; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA;

EID: 0032497584     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202080     Document Type: Article

References (25)

1. Berg C, Hedrum A, Holmberg A, Pontén F, Uhlén M and Lundeberg J. (1995). Clin. Chem., 41, 1461-1466.
2. Eklund LK, Holmberg E, Undén AB, Lundh-Rozell B, Ståhle-Bäckdahl M, Zaphiropoulos PG, Toftgård R and Söderkvist P. (1997). Molecular Carcinogenesis. In press.
3. Fearon ER and Vogelstein B. (1990). Cell, 61, 759-767.
4. Futreal PA, Barrett JC and Wiseman RW. (1991). Nucleic Acids Res., 19, 6977.
5. Gailani MR, Bale SJ, Leffell DJ, DiGiovanna JJ, Peck GL, Poliak S, Drum MA, Pastakia B, McBride OW, Kase R et al. (1992). Cell, 69, 111-117.
6. Gailani MR, Stähle-Bäckdahl M, Leffell DJ, Glynn M, Zaphiropoulos PG, Pressman C, Unden AB, Dean M, Brash DE, Bale AE and Toftgård R. (1996). Nat. Genet., 14, 78-81.
7. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M and Weissenbach J. (1994). Nat. Genet., 7, 246-339.
8. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrard B, Goldstein AM, Dean M, Toftgård R, Chenevix-Trench G, Wainwright B and Bale AE. (1996). Cell, 85, 841-851.
9. Hedrum A, Pontén F, Ren Z, Lundeberg J, Pontén J and Uhlén M. (1994). BioTechniques, 17, 118-129.
10. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.
11. Holmberg E, Rozell BL and Toftgård R. (1996). Br. J. Cancer, 74, 246-250.
12. Hultman T, Bergh S, Moks T and Uhlen M. (1991). Biotechniques, 10, 84-93.
13. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein EH Jr and Scott MP. (1996). Science, 272, 1668-1671.
14. Jones HM and Nakamura Y. (1992). Genes Chromosomes Cancer, 5, 89-90.
15. Knudson AG Jr. (1971). Proc. Natl. Acad. Sci. USA. 68, 820-823.
16. Pontén F, Berne B, Ren ZP, Nister M and Ponten J. (1995). J. Invest. Dermatol., 105, 402-406.
17. Pontén F, Williams C, Gao L, Ahmadian A, Nistér M, Lundeberg J, Pontén J and Uhlén M. (1997). Mutation Res. Genet., 382, 45-55.
18. Quinn AG, Campbell C, Healy E and Rees JL. (1994a). J. Invest. Dermatol., 102, 300-303.
19. Quinn AG, Sikkink S and Rees JL. (1994b). Cancer Res., 54, 4756-4759.
20. Rehman I, Quinn AG, Healy E and Rees JL. (1994). Lancet, 344, 788-789.
21. Ren ZP, Ahmadian A, Pontén F, Nister M, Berg C, Lundeberg J, Uhlén M and Pontén J. (1997). Am. J. Pathol., 150, 1791-1803.
22. Ren ZP, Hedrum A, Pontén F, Nister M, Ahmadian A, Lundeberg J, Uhlén M and Pontén J. (1996). Oncogene, 12, 765-773.
23. Unden AB, Zaphiropoulos PG, Bruce K, Toftgård R and Stahle-Baekdahl M. (1997). Cancer Res., 57, 2336-2340.
24. Vogelsteín B & Kinzler KW. (1993). Trends Genet., 9, 138-141.
25. Zaphiropoulos PG, Söderkvist P, Hedblad MA and Toftgård R. (1994). Biochem. Biophys. Res. Commun., 201, 1495-1501.